NMT Medical, AGA Medical settle
This article was originally published in The Gray Sheet
Executive Summary
In return for full and final settlement of NMT's 1999 patent infringement suit, AGA will pay NMT $30 mil. for a nonexclusive sublicense to patent '420, which relates to NMT's CardioSeal, the two firms announced March 28. The alleged infringement affects all AGA Amplatzer occluding devices. NMT will split the settlement with inventor Lloyd Marks, MD, according to the firm. NMT competes with AGA in the patent foramen ovale occlusion market with STARFlex. Preliminary results of NMT's MIST I trial suggest a connection between patent foramen ovale closure and migraine symptoms (1"The Gray Sheet" March 20, 2006, p. 3)...You may also be interested in...
MIST Trial Reveals Mixed Results For PFO Treatment Of Migraine
Preliminary clinical trial data show NMT Medical's STARflex patent foramen ovale (PFO) closure device to be no more effective than placebo in completely eliminating migraine headaches, although the device did appear to improve some symptoms
FDA Commissioner Nominee Hahn Advances To Full Senate, Despite Some Dems’ Reservations
Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.
FDA Holding February Public Meeting On Using AI In Radiology
The US agency will host a two-day meeting to discuss the evolution of artificial intelligence technology used to analyze radiological images when diagnosing patients and in advising radiologists to take optimal pictures. The takeaways from the meeting will be used by the FDA to help it develop its thinking on how to regulate such technology.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: